168 related articles for article (PubMed ID: 6169130)
1. Studies on vaccine control and immunogenicity of polysaccharides of Streptococcus pneumoniae.
Lee CJ; Lin KT
Rev Infect Dis; 1981; 3 Suppl():S51-60. PubMed ID: 6169130
[TBL] [Abstract][Full Text] [Related]
2. The quantitative immunochemical determination of pneumococcal and meningococcal capsular polysaccharides by light scattering rate nephelometry.
Lee CJ
J Biol Stand; 1983 Jan; 11(1):55-64. PubMed ID: 6403547
[TBL] [Abstract][Full Text] [Related]
3. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
Chu RS; McCool T; Greenspan NS; Schreiber JR; Harding CV
Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
[TBL] [Abstract][Full Text] [Related]
4. Immune response of neonates to pneumococcal polysaccharide-protein conjugate.
Lin KT; Lee CJ
Immunology; 1982 Jun; 46(2):333-42. PubMed ID: 7200956
[TBL] [Abstract][Full Text] [Related]
5. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.
Sorensen RU; Leiva LE; Giangrosso PA; Butler B; Javier FC; Sacerdote DM; Bradford N; Moore C
Pediatr Infect Dis J; 1998 Aug; 17(8):685-91. PubMed ID: 9726341
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and reactogenicity of new multivalent pneumococcal vaccines.
Wiedermann G; Jovanovic D; Georges AM; Hauser P; Ambrosch F
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Apr; 251(4):494-504. PubMed ID: 7201725
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses in adult volunteers to pneumococcal polysaccharide types 19F and 19A administered singly and in combination.
Penn RL; Lewin EB; Douglas RG; Schiffman G; Lee CJ; Robbins JB
Infect Immun; 1982 Jun; 36(3):1261-2. PubMed ID: 7095850
[TBL] [Abstract][Full Text] [Related]
8. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.
Ahman H; Käyhty H; Tamminen P; Vuorela A; Malinoski F; Eskola J
Pediatr Infect Dis J; 1996 Feb; 15(2):134-9. PubMed ID: 8822286
[TBL] [Abstract][Full Text] [Related]
9. Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide--pneumolysoid conjugate.
Lee CJ; Lock RA; Andrew PW; Mitchell TJ; Hansman D; Paton JC
Vaccine; 1994 Aug; 12(10):875-8. PubMed ID: 7975828
[TBL] [Abstract][Full Text] [Related]
10. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children.
Leinonen M; Säkkinen A; Kalliokoski R; Luotonen J; Timonen M; Mäkelä PH
Pediatr Infect Dis; 1986; 5(1):39-44. PubMed ID: 3945574
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model.
Giebink GS; Meier JD; Quartey MK; Liebeler CL; Le CT
J Infect Dis; 1996 Jan; 173(1):119-27. PubMed ID: 8537648
[TBL] [Abstract][Full Text] [Related]
12. The immunogenicity of pneumococcal polysaccharides in infants and children: a meta-regression.
Laferriere C
Vaccine; 2011 Sep; 29(40):6838-47. PubMed ID: 21816198
[TBL] [Abstract][Full Text] [Related]
13. Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides.
Biagini RE; Schlottmann SA; Sammons DL; Smith JP; Snawder JC; Striley CA; MacKenzie BA; Weissman DN
Clin Diagn Lab Immunol; 2003 Sep; 10(5):744-50. PubMed ID: 12965898
[TBL] [Abstract][Full Text] [Related]
14. C-polysaccharide in a pneumococcal vaccine.
Sørensen UB; Henrichsen J
Acta Pathol Microbiol Immunol Scand C; 1984 Dec; 92(6):351-6. PubMed ID: 6084398
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
16. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination.
Koskela M
Pediatr Infect Dis J; 1987 Jun; 6(6):519-26. PubMed ID: 3615065
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens.
Dagan R; Melamed R; Zamir O; Leroy O
Pediatr Infect Dis J; 1997 Nov; 16(11):1053-9. PubMed ID: 9384339
[TBL] [Abstract][Full Text] [Related]
18. Maternal immunity and antibody response of neonatal mice to pneumococcal type 19F polysaccharide.
Lee CJ; Ching ED; Vickers JH
J Clin Microbiol; 1991 Sep; 29(9):1904-9. PubMed ID: 1774315
[TBL] [Abstract][Full Text] [Related]
19. Reactivity and antibody responses of volunteers given two or three doses of pneumococcal vaccine.
Mufson MA; Krause HE; Schiffman G
Proc Soc Exp Biol Med; 1984 Nov; 177(2):220-5. PubMed ID: 6483857
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal antibody levels one decade after immunization of healthy adults.
Mufson MA; Krause HE; Schiffman G; Hughey DF
Am J Med Sci; 1987 May; 293(5):279-84. PubMed ID: 3591818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
